levodopa has been researched along with Brain Inflammation in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (30.77) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angius, F; Batetta, B; Carboni, E; Carta, AR; Cossu, G; Espa, E; Fenu, S; Giuffrida, A; Jadžić, D; Lecca, D; Mulas, G; Pillai, E; Simbula, G; Spiga, S; Spolitu, S | 1 |
Brundin, P; Cenci, MA; Lane, EL; Soulet, D; Vercammen, L | 1 |
Barnum, CJ; Bishop, C; Blandino, P; Deak, T; Dupre, K; Eskow, KL | 1 |
Koning, L | 1 |
Cossu, G; Ferrigno, P; Manca, D; Marcia, E; Melis, M; Molari, A; Murgia, D | 1 |
Castro, A; Dapena, MD; Linazasoro, G; Van Blercom, N | 1 |
Gerber, JC; Grossman, MH; Hare, TA; Katz, L; Manyam, NV | 1 |
Sacks, OW | 1 |
Collard, M; Hirsch, E; Marescaux, C; Picard, F; Salmon, E | 1 |
de Saint-Martin, A; Hirsch, E; Marescaux, C; Picard, F; Salmon, E | 1 |
Asano, M; Kohanawa, M; Min, Y; Minagawa, T | 1 |
Chandra, B | 1 |
Barrett, RE; Cote, LJ; Fahn, S; Isgreen, WP; Lesser, RP; Snider, SR | 1 |
1 trial(s) available for levodopa and Brain Inflammation
Article | Year |
---|---|
Treatment of disturbances of consciousness caused by measles encephalitis with levodopa.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Coma; Double-Blind Method; Electroencephalography; Encephalitis; Female; Humans; Levodopa; Male; Measles; Placebos | 1978 |
12 other study(ies) available for levodopa and Brain Inflammation
Article | Year |
---|---|
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Cytokines; Disease Models, Animal; Drug Delivery Systems; Dyskinesia, Drug-Induced; Encephalitis; Functional Laterality; Gene Expression Regulation; Levodopa; Lipopolysaccharides; Male; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympatholytics; Tumor Necrosis Factor-alpha | 2016 |
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
Topics: Adrenergic Agents; Amphetamine; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Antiparkinson Agents; Brain Tissue Transplantation; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dyskinesias; Embryo, Mammalian; Encephalitis; Female; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Levodopa; Mesencephalon; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rats, Wistar; Skin Transplantation | 2008 |
Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.
Topics: Animals; Anti-Inflammatory Agents; Corpus Striatum; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Encephalitis; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Levodopa; Male; Medial Forebrain Bundle; Neural Pathways; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substantia Nigra; Sympatholytics; Up-Regulation | 2008 |
[Encephalitis lethargica in the Netherlands; renewed interest in a mysterious disease].
Topics: Autoimmune Diseases of the Nervous System; Basal Ganglia; Disease Outbreaks; Dopamine Agents; Encephalitis; History, 20th Century; Humans; Levodopa; Netherlands; Treatment Failure | 2009 |
Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.
Topics: Aged; Antiparkinson Agents; Catechols; Encephalitis; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Peripheral Nervous System Diseases | 2009 |
Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.
Topics: Analgesics, Non-Narcotic; Anti-Infective Agents; Antiparkinson Agents; Combined Modality Therapy; Consciousness Disorders; Dantrolene; Deep Brain Stimulation; Diagnosis, Differential; Diagnostic Errors; Dystonic Disorders; Encephalitis; Female; Fluid Therapy; Foot; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Muscle Relaxants, Central; Parkinson Disease; Selegiline; Substance Withdrawal Syndrome; Tachycardia | 2004 |
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
Topics: Brain Chemistry; Cerebellar Diseases; Creatine Kinase; Dementia; Diet; Encephalitis; Epilepsy; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hypoxia; Levodopa; Multiple Sclerosis; Muscular Dystrophies; Nervous System Diseases; Parkinson Disease; Tissue Preservation | 1980 |
Acquired Tourettism in adult life.
Topics: Adult; Encephalitis; Humans; Levodopa; Middle Aged; Nervous System Diseases; Tourette Syndrome | 1982 |
[Parkinsonian syndrome and post-encephalitic stereotyped involuntary movements responsive to L-dopa].
Topics: Adult; Dopamine Agents; Encephalitis; Encephalitis, Viral; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease, Postencephalitic; Time Factors | 1996 |
Postencephalitic stereotyped involuntary movements responsive to L-Dopa.
Topics: Adult; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Encephalitis; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine D2; Stereotyped Behavior; Tomography, X-Ray Computed; Trihexyphenidyl | 1996 |
Movement disorders in encephalitis induced by Rhodococcus aurantiacus infection relieved by the administration of L-dopa and anti-T-cell antibodies.
Topics: Actinomycetales Infections; Animals; Antiparkinson Agents; Autoantibodies; Brain; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Colony Count, Microbial; Combined Modality Therapy; Encephalitis; Female; Flow Cytometry; Levodopa; Mice; Movement Disorders; Rhodococcus; Statistics, Nonparametric | 1999 |
Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy.
Topics: Adolescent; Adult; Aged; Chorea; Encephalitis; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1979 |